Rivaroxaban Tablet is a coagulation factor inhibitor that inhibits the activity of coagulation factor Xa to exert an anticoagulant effect, and can be used to prevent the formation of venous thrombosis in patients undergoing surgery, such as elective hip replacement, and to reduce the risk of systemic embolism and stroke in patients with non-valvular atrial fibrillation with risk factors, pulmonary embolism, and deep vein thrombosis. Side effects such as bleeding, thrombocytopenia, jaundice, angioedema may occur while taking the drug. Rivaroxaban is contraindicated in patients who are hypersensitive to rivaroxaban or to any of the excipients in the tablets; who have clinically significant active bleeding; who are pregnant or breastfeeding; who are at significant risk of major bleeding such as those with recent or current gastrointestinal ulcers; who are at clinical risk of bleeding and have coagulation abnormalities, including those with cirrhosis of Child-Pugh B and C; who are taking other anticoagulants such as normal heparin, low molecular heparin, warfarin, etc. etc. Treatment must be discontinued if acute renal failure occurs during administration. This drug is not recommended for patients under 18 years of age. If you need to use the drug, please be sure to follow the doctor’s instructions strictly, do not use the drug on your own.